METAGENOMI INC (MGX) Stock Income Statement
NASDAQ:MGX - Nasdaq - US59102M1045 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 52.30M | 44.76M | 17.20M | 243.00K | |||
| Operating Expenses | 141.20M | 123.25M | 61.84M | 24.19M | |||
| Research and Development | 109.18M | 94.40M | 43.14M | 14.48M | |||
| Selling, General, and Administrative Expenses | 32.02M | 28.84M | 18.70M | 9.71M | |||
| Operating Income | -88.90M | -78.49M | -44.64M | -23.95M | |||
| Interest Income/Expense | 5.54M | 18.34M | 3.42M | 2.50M | |||
| Other Income/Expense | -207.00K | -74.00K | 201.00K | 4.00K | |||
| Income Before Taxes | -83.57M | -60.23M | -41.02M | -21.44M | |||
| Income Tax | -5.51M | 8.03M | 2.57M | 0.00 | |||
| Net Income | -78.06M | -68.25M | -43.59M | -21.44M | |||
| EBITDA | -83.49M | -74.28M | -42.91M | -23.56M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -2.36 | -1.82 | -1.16 | -0.57 | |||
| Non GAAP EPS | -2.62 | N/A | N/A | N/A | |||
| Statistics | |||||||
| Profit Margin | -149.26% | -152.50% | -253.45% | -8823.87% | |||
| Operating Profit Margin | -170.00% | -175.38% | -259.53% | -9854.73% | |||
All data in USD